Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.

The Diabetes Team at the Trust that runs Shropshire’s acute hospitals scooped the Public Recognition Award at its annual ...

Ever had a boss whose requests were so infuriating, you felt like screaming into a pillow? We’ve all been there, gritting our ...

Among 91 women, those who used a closed-loop insulin delivery system spent an average of 65.4% of time in pregnancy-specific ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its ...

I never had a Barbie with dark hair, brown eyes and an insulin pump when I was growing up. But today’s girls can. And that is ...

A Polish study comparing insulin pump technologies in children with type 1 diabetes found that advanced hybrid closed-loop ...

In a step that could change the lives of millions of diabetes patients, researchers from the Indiana University School of Medicine in the United States have successfully designed a hybrid molecule ...

Stifel has resumed coverage of several medtech companies, citing steady adoption of continuous glucose monitors (CGMs) and insulin pumps as key drivers for growth.

The United States Rapid Acting Insulin Market is poised for significant growth, increasing from US$ 2.32 Billion in 2024 to US$ 3.40 Billion by 2033, with a CAGR of 4.33%. Key growth drivers include ...

The FDA has accepted for review the sBLA for Afrezza (insulin human) inhalation powder in children and adolescents with type 1 or 2 diabetes.

A research team at Indiana University School of Medicine has developed a novel laboratory-designed protein that combines ...